Suppr超能文献

一氧化氮合酶内源性抑制剂对链脲佐菌素诱导的糖尿病大鼠肝线粒体功能障碍的作用

Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats.

作者信息

Chen Na, Leng Yi-Ping, Xu Wen-Juan, Luo Jian-Dong, Chen Min-Sheng, Xiong Yan

机构信息

Department of Pharmacology, Guangzhou Medical University, Guangzhou, PR China.

出版信息

Cell Physiol Biochem. 2011;27(3-4):341-52. doi: 10.1159/000327960. Epub 2011 Apr 1.

Abstract

AIMS

Mitochondrial dysfunction plays important roles in the development of diabetes. Elevated nitric oxide (NO) synthase inhibitor asymmetric dimethylarginine (ADMA) has been shown to be closely related to diabetes. But the relationship between them in diabetes has not been determined. This study was to explore the role of ADMA in hepatic mitochondrial dysfunction and its potential mechanisms in diabetic rats and hepatocytes.

METHODS

Respiratory enzymes activities, mitochondrial transmembrane potential and ATP content were measured to evaluate mitochondrial function. The copy number ratio of mitochondrial gene to nuclear gene was used to represent mitochondrial biogenesis. The activity of superoxide dismutase and malondialdehyde content were detected to reflect oxidative stress. Furthermore, changes in ADMA and NO contents, uncoupling protein 2 (UCP2) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) transcriptions were determined.

RESULTS

Elevated ADMA levels in serum of diabetic rats were found to be associated with hepatic mitochondrial dysfunction reflected by reductions of respiratory enzyme activities, mitochondrial membrane potential and ATP contents. Similar mitochondrial dysfunction also occurred in ADMA-treated hepatocytes. The mitochondrial dysfunction observed in diabetic rats or hepatocytes was accompanied with suppressions of mitochondrial biogenesis, PGC-1α transcription and NO synthesis as well as enhances of UCP 2 transcription and oxidative stress. These effects of ADMA could be attenuated by treatments with antioxidant or NO donor.

CONCLUSIONS

These results indicate that elevated endogenous ADMA contributes to hepatic mitochondrial dysfunction in diabetic rats, and underlying mechanisms may be related to the suppression of mitochondrial biogenesis and mitochondrial uncoupling via inhibiting NO synthesis and enhancing oxidative stress.

摘要

目的

线粒体功能障碍在糖尿病的发生发展中起重要作用。一氧化氮(NO)合酶抑制剂非对称二甲基精氨酸(ADMA)水平升高已被证明与糖尿病密切相关。但二者在糖尿病中的关系尚未明确。本研究旨在探讨ADMA在糖尿病大鼠和肝细胞肝线粒体功能障碍中的作用及其潜在机制。

方法

检测呼吸酶活性、线粒体跨膜电位和ATP含量以评估线粒体功能。用线粒体基因与核基因的拷贝数比值代表线粒体生物合成。检测超氧化物歧化酶活性和丙二醛含量以反映氧化应激。此外,测定ADMA和NO含量、解偶联蛋白2(UCP2)和过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)转录水平的变化。

结果

发现糖尿病大鼠血清中升高的ADMA水平与肝线粒体功能障碍有关,表现为呼吸酶活性、线粒体膜电位和ATP含量降低。ADMA处理的肝细胞也出现类似的线粒体功能障碍。在糖尿病大鼠或肝细胞中观察到的线粒体功能障碍伴随着线粒体生物合成、PGC-1α转录和NO合成的抑制以及UCP 2转录和氧化应激的增强。ADMA的这些作用可通过抗氧化剂或NO供体治疗得到减轻。

结论

这些结果表明,内源性ADMA升高导致糖尿病大鼠肝线粒体功能障碍,其潜在机制可能与通过抑制NO合成和增强氧化应激来抑制线粒体生物合成和线粒体解偶联有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验